Physician

Kavita B Kalra, M.D.

According to 2025 Medicare claims, Kavita Kalra, M.D. (NPI: 1063495232) practices hematology/oncology in the Baltimore-Columbia-Towson, MD market, with the plurality of this provider's patient population coming from Baltimore, MD. This provider's primary affiliated billing organization is BALTIMORE ONCOLOGY HEMATOLOGY ASSOCIATES LLC (NPI: 1598972259) and primary practice location at 21201-6302.

Kalra's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 584 traditional Medicare patients, billed 279,538 HCPCS/CPT codes, and received $3,992,403 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,096 prescription claims across 254 beneficiaries totaling $11,088,605 in drug costs, led by Tepezza (Teprotumumab-Trbw). 2016 DME data shows 16 claims. Open Payments data shows 90 records totaling $5,092. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $557,531 to $3,992,403. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,050,256 to $11,088,605. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$4.0M2015 Medicare payment: $557,531 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $570,670 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $985,748 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,673,660 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,816,117 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,207,567 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,118,675 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $846,594 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,425,945 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,992,403 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201516633,020$557,531
201618230,143$570,670
201724242,540$985,748
201823386,265$1,673,660
201923762,067$1,816,117
202021275,467$2,207,567
202121571,097$2,118,675
202224941,264$846,594
2023493160,971$2,425,945
2024584279,538$3,992,403

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$6.2M$12M2015 Drug cost: $1,050,256 (USD; Tot_Drug_Cst)2016 Drug cost: $844,561 (USD; Tot_Drug_Cst)2017 Drug cost: $2,268,102 (USD; Tot_Drug_Cst)2018 Drug cost: $3,911,634 (USD; Tot_Drug_Cst)2019 Drug cost: $4,754,014 (USD; Tot_Drug_Cst)2020 Drug cost: $6,146,610 (USD; Tot_Drug_Cst)2021 Drug cost: $6,476,800 (USD; Tot_Drug_Cst)2022 Drug cost: $11,229,802 (USD; Tot_Drug_Cst)2023 Drug cost: $12,385,897 (USD; Tot_Drug_Cst)2024 Drug cost: $11,088,605 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015110610$1,050,256
2016107597$844,561
201797659$2,268,102
2018123877$3,911,634
2019138836$4,754,014
2020139837$6,146,610
2021153750$6,476,800
20222341,006$11,229,802
20232731,063$12,385,897
20242541,096$11,088,605

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$8.6K$17K2016 Medicare payment: $17,190 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/R16$17,190
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/RN/RN/R
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more74129$99
96365Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less166487$51
96372Injection of drug or substance under skin or into muscle2861,339$12
J1306Injection, inclisiran, 1 mg15880,662$9
J3489Injection, zoledronic acid, 1 mg85416$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TepezzaTeprotumumab-Trbw33693$2,427,661
OcrevusOcrelizumab539,360$1,930,548
KrystexxaPegloticase13364$715,796
CalquenceAcalabrutinib Maleate33990$485,649
PrivigenImmun Glob G(Igg)/Pro/Iga 0-5024998$458,773

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.90$5,092AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Kavita B. Kalra, M.D.?

Tedicare shows public-source Medicare data for Kavita B. Kalra, M.D. (NPI 1063495232), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kavita B. Kalra, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Kavita B. Kalra, M.D.?

Kavita B. Kalra, M.D. is linked to BALTIMORE ONCOLOGY HEMATOLOGY ASSOCIATES LLC (billing NPI 1598972259) in the available physician profile data.

Does Kavita B. Kalra, M.D. have Open Payments data?

Kavita B. Kalra, M.D. has 90 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.